Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure)-Reference-Cited by-同舟云学术

Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure)

Published:2024-07-02 Issue:1 Volume:19 Page:
ISSN:1862-3514
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Takada Junichi^ORCID,Okimoto Nobukazu^ORCID,Tsukamoto Manabu^ORCID,Akatsuka Tomohiro,Takebayashi Tsuneo,Iba Kousuke^ORCID,Ikeda Satoshi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11657-024-01415-1.pdf

Reference26 articles.

1. Orimo H, Nakamura T, Hosoi T et al (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos 7:3–20. https://doi.org/10.1007/s11657-012-0109-9

2. Takusari E, Sakata K, Hashimoto T et al (2020) Trends in hip fracture incidence in Japan: estimates based on nationwide hip fracture surveys from 1992 to 2017. JBMR Plus 5:e10428. https://doi.org/10.1002/jbm4.10428

3. Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med 377:1417–1427. https://doi.org/10.1056/NEJMoa1708322

4. Al-Lamee R, Thompson D, Dehbi HM et al (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 391:31–40. https://doi.org/10.1016/S0140-6736(17)32714-9

5. Hagino H, Sugimoto T, Tanaka S et al (2021) A randomized, controlled trial of 1/W teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Osteoporos Int 32:2301–2311. https://doi.org/10.1007/s00198-021-05996-2